MetLife, Inc. is a leading global provider of insurance, annuities and employee benefit programs, serving 90 million customers. Through its subsidiaries and affiliates, MetLife holds leading market positions in the United States, Japan, Latin America, Asia, Europe, the Middle East and Africa. MetLife has operated as a good corporate citizen. Building on their long legacy of excellence, they are committed to ensuring a future in which they can continue helping people and communities around the world navigate life together.
Industry sector: Finance
Sector classification: Life insurance
Deep Learning based analysis and prediction model for MetLife, Inc. (MET) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 22, 2015.
Market data for MET model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are
accounted for in this model in the form of the historical data coincided with outbreaks and other
global events in the past used to train ML prediction model for MET.
Model is being retrained on a daily basis.
| Float | 1015M |
| P/E | 9.27 |
| Shares Outstanding | 1019M |
| % Held by Insiders | 0.32% |
| % Held by Institutions | 77.65% |
| EPS (last reported FY) | $4.50 |
| EPS (last reported Q) | $1.36 |
| EPS, estimated (last reported Q) | $1.17 |
| Total revenues | $62 B |
| Net income | $4 B |